BusinessLegalPipelineResearchEventsProducts
Browse All Stories »
FEATURED
Eyenovia and Senju to develop chronic dry eye drop-device combo

Eyenovia and Senju to develop chronic dry eye drop-device combo

Collaboration features the Optejet dosing delivery system delivering a corneal epithelial wound healing-ophthalmic solution.

Earn FREE CE 24/7 with Courses by Eyes On Eyecare

Check it out

Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.

TRENDING
Videos
Ophthalmology Tech Forum to showcase groundbreaking industry innovations
Ophthalmology Tech Forum to showcase groundbreaking industry innovations
CooperVision and AOA launch The Myopia Collective
CooperVision and AOA launch The Myopia Collective
Barti introduces AI transcription tech for optometrists
Barti introduces AI transcription tech for optometrists
Rinsada's irrigating eyelid retractor targets ocular surface restoration
Rinsada's irrigating eyelid retractor targets ocular surface restoration
Watch More
Business
Bausch + Lomb acquires Trukera Medical
Bausch + Lomb acquires Trukera Medical
Opthea selects global retinal leaders for Medical Advisory Board
Opthea selects global retinal leaders for Medical Advisory Board
Sydnexis names long-time industry executive as new leader
Sydnexis names long-time industry executive as new leader
EssilorLuxottica is purchasing a majority stake in Heidelberg Engineering
EssilorLuxottica is purchasing a majority stake in Heidelberg Engineering
Research
ADHD medications may lead to increased glaucoma risk
ADHD medications may lead to increased glaucoma risk
Systemic factors tied to retinal microvascular parameters in diabetic patients
Systemic factors tied to retinal microvascular parameters in diabetic patients
Physically active kids less likely to develop myopia
Physically active kids less likely to develop myopia
Vabysmo provides long-term durability in DME extension study
Vabysmo provides long-term durability in DME extension study
Pipeline
Eyenovia and Senju to develop chronic dry eye drop-device combo
Eyenovia and Senju to develop chronic dry eye drop-device combo
Beacon Therapeutics to evaluate patented AAV gene therapy for retinal diseases
Beacon Therapeutics to evaluate patented AAV gene therapy for retinal diseases
Beacon Therapeutic raises $170M for XLRP gene therapy development
Beacon Therapeutic raises $170M for XLRP gene therapy development
Ocugen doses first patient in phase 3 RP gene therapy trial
Ocugen doses first patient in phase 3 RP gene therapy trial
Products
Osheru raises $4.7M to advance blepharoplasty surgical device
Osheru raises $4.7M to advance blepharoplasty surgical device
Spryte Medical earns FDA Breakthrough Device Designation for nOCT tech
Spryte Medical earns FDA Breakthrough Device Designation for nOCT tech
FDA clears Oertli's Faros anterior cataract surgery system
FDA clears Oertli's Faros anterior cataract surgery system
SUSVIMO phase 3 data supports sustained efficacy for DR, DME
SUSVIMO phase 3 data supports sustained efficacy for DR, DME
Legal
Optometry excluded in new DC scope of practice legislation
Optometry excluded in new DC scope of practice legislation
FTC adds final compliance-targeted updates to Eyeglass Rule
FTC adds final compliance-targeted updates to Eyeglass Rule
Public support needed for landmark pediatric vision and eye health legislation
Public support needed for landmark pediatric vision and eye health legislation
Alcon faces penalty over Sight Sciences patent infringement
Alcon faces penalty over Sight Sciences patent infringement
Archives
Hello 2023 — Weekly Glance
Hello 2023 — Weekly Glance
Can we treat uveitis without steroids? — Weekly Glance
Can we treat uveitis without steroids? — Weekly Glance
Can I have one dilation drop instead of two? — Weekly Glance
Can I have one dilation drop instead of two? — Weekly Glance
Are those dilation reversal drops available yet? — Weekly Glance
Are those dilation reversal drops available yet? — Weekly Glance
Events
Investors and key therapeutic areas are determining the state of the ophthalmic market
Investors and key therapeutic areas are determining the state of the ophthalmic market
Registration opens for Eyes On Retina 2024
Registration opens for Eyes On Retina 2024
Experts weigh in on key trends in anterior segment innovations
Experts weigh in on key trends in anterior segment innovations
Ophthalmology Tech Forum 2024 breaks new ground in innovations
Ophthalmology Tech Forum 2024 breaks new ground in innovations
Browse All Stories »